Open registration: AI-designed antibodies, with Lurong Pan, October 17
Episode 4 of NAPPA Healthcare & Biopharma Insights looks at sequence-based AI antibody design through more than a hundred success cases.
NAPPA’s thought-leadership webinar series — NAPPA Healthcare & Biopharma Insights — continues on Saturday, October 17, 2026, 9:00–10:00 PM ET with Episode 4: AI-Designed Antibodies That Work: 100+ Success Cases Across Targets and Modalities.
The episode is led by Dr. Lurong Pan, Founder and Chief Executive Officer of Ainnocence Inc. She presents sequence-based AI design for novel and difficult targets, with results across antibodies, VHH/nanobodies, bispecifics, antibody-drug conjugates (ADCs), and more.
What’s covered
- Sequence-based AI design of antibodies
- Applying AI design to novel and difficult targets
- Results across antibodies, VHH/nanobodies, bispecifics, ADCs, and more
- Lessons from 100+ success cases across targets and modalities
Register
Registration is free for NAPPA members and qualified industry guests. Seats are limited; join details are sent by email after registering.